In H1FY26, total revenue of the Sai Life Sciences increased by 53% YoY at ₹1,034 crore, driven by healthy growth across both the CRO and the CDMO business.
At 11:29 AM, Laurus Labs' stock was quoting 2 per cent higher at ₹943.15 on the BSE, commanding an m-cap of ₹50,913 crore, exchange data shows
A host of lesser-known vaccine makers are eyeing contract manufacturing opportunities for global and domestic majors
Contract manufacturers claim that at least 40-60% of pharmaceutical manufacturing in the country is outsourced by big pharma